{"schemaVersion":"ready-scan.discovery-surface.v1","id":"urn:readyscan:corpus:buyer-question:insphero-q117168604-answer-fa33e17cc89f54d3ef36","key":"buyer_question:insphero-q117168604-answer-fa33e17cc89f54d3ef36","kind":"buyer_question","slug":"insphero-q117168604-answer-fa33e17cc89f54d3ef36","canonicalUrl":"https://directory.readyscan.ai/corpus/buyer-question/insphero-q117168604-answer-fa33e17cc89f54d3ef36","machineUrl":"https://directory.readyscan.ai/discovery/corpus/buyer-question/insphero-q117168604-answer-fa33e17cc89f54d3ef36.json","datePublished":"2026-10-22","dateModified":"2026-10-22","materialFingerprint":"fnv1a64:d22ebc6cbd8430c8","membershipFingerprint":"fnv1a64:0997aa82b1e7b13f","relatedEntitySlugs":["insphero-q117168604"],"relatedSurfaceKeys":["buyer_question:insphero-q117168604-answer-1ff7e6911a609c45a951","buyer_question:insphero-q117168604-answer-30b3729812b73c1ba24a","buyer_question:insphero-q117168604-answer-4cfd141de5b7d792bd29","buyer_question:insphero-q117168604-answer-744be800fa812980d42d","buyer_question:insphero-q117168604-answer-8617333385926f9c4dac","buyer_question:insphero-q117168604-answer-8dccd9a21eff9fbd1b8e","buyer_question:insphero-q117168604-answer-9a3bf6e59cdd2e914114","buyer_question:insphero-q117168604-answer-b2b3e670f0ef5829045f","evidence:insphero-q117168604"],"sourceIds":["ready-scan-subjects"],"provenance":[{"snapshotId":"insphero-q117168604-content-1f44a97404899859-snapshot","sourceId":"ready-scan-subjects","sourceRecordId":"Q117168604","sourceRevisionId":"Q117168604:content:441d4518f50769db","sourceContentHash":"fnv1a64:725b9340b870f153","recordRevisionId":"Q117168604:content:441d4518f50769db","recordContentHash":"fnv1a64:b2135b8c72cee765","sourceCanonicalUrl":"https://insphero.com/","sourceModifiedAt":"2026-10-22T11:09:56.736Z","observedOn":"2026-10-22","permission":{"basis":"public_information","evidenceUrl":"https://insphero.com/"},"attributionUrl":"https://insphero.com/"}],"quality":{"method":"same_kind_unique_trigram_floor","minimumUniqueTrigramRatio":0.3,"status":"passed"},"title":"Can 3D neural microtissues be used for chronic toxicity studies?","summary":"Cited source answers across 1 active corpus record.","question":"Can 3D neural microtissues be used for chronic toxicity studies?","answers":[{"entitySlug":"insphero-q117168604","entityName":"InSphero","answer":"“Yes. 3D InSight™ Human Neural Microtissues remain viable and functionally active for up to 8 weeks after aggregation, providing an assay window of up to 4 weeks upon delivery. This enables long-term compound exposure studies designed to better reflect clinical dosing regimens.”","sourceUrls":["https://insphero.com/solutions/human-neural-microtissues/"]}]}